Follow us for updates
© 2020 reportr.world
Read the Story →

Tycoons Pitch In for COVID-19 Vaccine Drive

Tycoons are helping out.
by Arianne Merez
Just now
Photo/s: National Cancer Institute / Unsplash
Shares

The Philippines' top businessmen said they were chipping in to ensure the availability of COVID-19 vaccines as the government moves to immunize millions to help end the pandemic.

Among businessmen joining the initiative are Ayala Corp's Jaime Augusto Zobel de Ayala, port magnate Enrique Razon, taipan Lucio Tan, and the children of late SM shopping mall tycoon Henry Sy Sr.

"Our task extends, beyond procuring vaccines, towards helping optimize the end-to-end supply chain and distribution logistics. In this next frontier of combatting COVID 19, the private sector remains committed to our partnership with the public sector and, ultimately, to our fellow Filipinos," Zobel said in a statement.

Earlier, International Container Terminal Services Inc. said Razon would shoulder the full cost of a portion of the country's vaccine requirement, half of which will be given to employees of his conglomerate while the remainder will be reserved for port and customs employees and logistics frontliners.

Continue reading below ↓

ALSO READ:

Enrique Razon to Help Fund Philippines' COVID Vaccine Purchases

Philippines to Sign Deal with UK's Astra Zeneca for 2 Million COVID Vaccines

Businessmen are part of Friday's tripartite deal with the government and British drugmaker AstraZeneca for the Philippines' plan to purchase some two million doses of COVID-19 vaccines.

“On Friday, November 27, we will sign a tripartite agreement to donate vaccines to the government which will augment their ongoing procurement initiatives," Presidential Adviser for Entrepreneurship Joey Concepcion said.

"We want to send a clear message to the Filipino people, especially our MSMEs, that there is hope, there is a light at the end of this dark tunnel," he said.

ALSO READ:

AstraZeneca, Oxford Say COVID-19 Vaccine Shows 70% Efficacy

Pfizer Seeks First Vaccine Approval in U.S.

Moderna COVID-19 Vaccine Almost 95% Effective: Trial

AstraZeneca earlier announced that its COVID-19 vaccine, which was developed with the University of Oxford has shown "an average efficacy of 70%" in trials. The results ranged between 62% and 90% efficacy depending on the vaccine dosage.

Continue reading below ↓

This however is lower compared with the efficacy of coronavirus vaccines trialed by rivals Pfizer/BioNTech and Moderna which have come in at around 95%.

The Philippines is eyeing to start immunizing its people against COVID-19 by the second quarter of next year.

Latest Headlines
Read Next
Recent News
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to reportr.world newsletter, you agree to our Terms of Service and Privacy Policy.